Literature DB >> 15087583

Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study.

Hélène Amieva1, Luc Letenneur, Jean-François Dartigues, Isabelle Rouch-Leroyer, Christophe Sourgen, Françoise D'Alchée-Birée, Michel Dib, Pascale Barberger-Gateau, Jean-Marc Orgogozo, Colette Fabrigoule.   

Abstract

Elderly subjects diagnosed with mild cognitive impairment (MCI) are becoming the target of intervention trials. The criteria used for MCI are principally issued from prospective clinical studies, although longitudinal population-based studies having identified several cognitive predictors of dementia can be of great contribution in the definition of these criteria. This study was conducted to explore the external validity of MCI criteria issued from a longitudinal population-based study, and subsequently to identify the best predictors of the short-term conversion to Alzheimer's disease 2 years after the MCI diagnosis. Ninety elderly volunteers with memory complaint diagnosed with MCI on the basis of their functional and neuropsychological performances were followed up within 2 years. The potential predictors of the conversion to dementia collected at baseline included age, gender, educational level, size of temporal lobe, apolipoprotein E genotype and a series of neuropsychological measures (Mac Nair Scale, Mini-Mental State Examination, Benton Visual Retention Test, Isaacs Set Test, Digit Symbol Substitution Task, Letter Cancellation Task, digit span tasks and finger-tapping test). Within the 2 years, 29 subjects (32.2%) presented a conversion to dementia. The risk of conversion to dementia was associated with age and size of temporal lobe but not with gender, education, or apolipoprotein E4 genotype. Several neuropsychological measures were associated with the risk of conversion to dementia, but in a logistic regression performed with the significant variables found in the univariate analysis, only the Letter Cancellation Test was shown to be an independent predictor. In conclusion, the quite elevated conversion rates obtained show the usefulness, when defining MCI criteria, of considering not only memory impairment but also impairment in other cognitive areas, as well as mild impairment on higher-order activities of daily living. Among the variables considered, the Letter Cancellation Test proved to be a major predictor of short-term conversion to dementia. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087583     DOI: 10.1159/000077815

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  34 in total

1.  Rate of progression from mild cognitive impairment to dementia in an essential tremor cohort: A prospective, longitudinal study.

Authors:  Keith H Radler; Maria Anna Zdrodowska; Hollie Dowd; Tess E K Cersonsky; Edward D Huey; Stephanie Cosentino; Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2020-04-15       Impact factor: 4.891

2.  Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example.

Authors:  Jeannie-Marie S Leoutsakos; Alexandra L Bartlett; Sarah N Forrester; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2013-08-15       Impact factor: 21.566

3.  Are subjective cognitive complaints a risk factor for dementia?

Authors:  Roberto Gallassi; Federico Oppi; Roberto Poda; Simona Scortichini; Michelangelo Stanzani Maserati; Gianfranco Marano; Luisa Sambati
Journal:  Neurol Sci       Date:  2010-02-25       Impact factor: 3.307

4.  High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.

Authors:  Andréy Mazarati; Mattia Maroso; Valentina Iori; Annamaria Vezzani; Mirjana Carli
Journal:  Exp Neurol       Date:  2011-08-22       Impact factor: 5.330

5.  Multiple cognitive deficits in amnestic mild cognitive impairment.

Authors:  Joel H Kramer; Adam Nelson; Julene K Johnson; Kristine Yaffe; Shenly Glenn; Howard J Rosen; Bruce L Miller
Journal:  Dement Geriatr Cogn Disord       Date:  2006-08-23       Impact factor: 2.959

6.  The fate of the 0.5s: predictors of 2-year outcome in mild cognitive impairment.

Authors:  Eleni Aretouli; Ozioma C Okonkwo; Jaclyn Samek; Jason Brandt
Journal:  J Int Neuropsychol Soc       Date:  2010-12-21       Impact factor: 2.892

7.  Prognosis of mild cognitive impairment in general practice: results of the German AgeCoDe study.

Authors:  Hanna Kaduszkiewicz; Marion Eisele; Birgitt Wiese; Jana Prokein; Melanie Luppa; Tobias Luck; Frank Jessen; Horst Bickel; Edelgard Mösch; Michael Pentzek; Angela Fuchs; Sandra Eifflaender-Gorfer; Siegfried Weyerer; Hans-Helmut König; Christian Brettschneider; Hendrik van den Bussche; Wolfgang Maier; Martin Scherer; Steffi G Riedel-Heller
Journal:  Ann Fam Med       Date:  2014 Mar-Apr       Impact factor: 5.166

8.  Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years.

Authors:  Marilyn Albert; Yuxin Zhu; Abhay Moghekar; Susumu Mori; Michael I Miller; Anja Soldan; Corinne Pettigrew; Ola Selnes; Shanshan Li; Mei-Cheng Wang
Journal:  Brain       Date:  2018-03-01       Impact factor: 13.501

Review 9.  Classification and epidemiology of MCI.

Authors:  Rosebud Roberts; David S Knopman
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

10.  Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging.

Authors:  Mary N Haan; Joshua W Miller; Allison E Aiello; Rachel A Whitmer; William J Jagust; Dan M Mungas; Lindsay H Allen; Ralph Green
Journal:  Am J Clin Nutr       Date:  2007-02       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.